Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 4/2011

01.08.2011 | Original Article

Prevention of Parent to Child Transmission of HIV (PPTCT): An Effort of 4 Years in a Tertiary Centre

verfasst von: Sebanti Goswami, Partha Sarathi Chakravorty

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to see the fetomaternal outcome of pregnancy in HIV positive mother.

Methods

This study was conducted in the department of OBGYN Medical College Kolkata from 1st January 2004 to 31st December 2007, a period of 4 years since the establishment of PPTCT centre in our institution. All the pregnant women attending the antenatal clinic for consultation and those coming directly to labour room for delivery (unbooked cases) were counseled for HIV testing, informed consent was obtained and blood samples collected for HIV testing. Babies of HIV positive women delivered were followed up to 18 months for testing.

Results

The no. of women detected positive were 28, 53, 69 and 98 (total 248) in the consecutive years. Therefore the seroprevalence of HIV was 0.41, 0.63, 0.67 and 0.76% in 2004, 2005, 2006 and 2007 respectively. Out of 248 women who were detected positive in the 3 years, only 103 (41.53%) delivered in our institution. 32 (12.90%) underwent MTP. But unfortunately 113 (i.e. 248 − (103 + 32) = 113) were lost to follow up during antenatal care. Out of the 95 live births, only 46 babies have been tested so far out of which only one is reactive, 45 are non reactive.

Conclusion

The main obstacle we faced was in following up the mother and the baby. To achieve a high success rate, PPTCT programmes must have well-trained, supportive staff who take great care to ensure confidentiality. They must be backed up by effective HIV testing and counseling programmes and by good quality HIV/AIDS education, which is essential to eliminate myths and misunderstandings among pregnant women, and to counter stigma and discrimination in the wider community.
Literatur
1.
Zurück zum Zitat Margolese S. Women and HIV. The Well Project. July 2003 (revised 2007). Margolese S. Women and HIV. The Well Project. July 2003 (revised 2007).
4.
Zurück zum Zitat WHO. Antiretroviral drugs for Treating pregnant women and Preventing HIV infection in infants: towards universal access recommendations for a public health approach. World Health Organization, Geneva: Published by WHO Press; 2006. WHO. Antiretroviral drugs for Treating pregnant women and Preventing HIV infection in infants: towards universal access recommendations for a public health approach. World Health Organization, Geneva: Published by WHO Press; 2006.
5.
Zurück zum Zitat WHO. Antiretroviral drugs for Treating pregnant women and Preventing HIV infection in infants: towards universal access recommendations for a public health approach. World Health Organization, Geneva: Published by WHO Press; 2006. WHO. Antiretroviral drugs for Treating pregnant women and Preventing HIV infection in infants: towards universal access recommendations for a public health approach. World Health Organization, Geneva: Published by WHO Press; 2006.
6.
7.
Zurück zum Zitat Colvin M, Chopra M, Doherty T, et al. Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV. Bull World Health Organ. 2007;85:466–73.PubMedCrossRef Colvin M, Chopra M, Doherty T, et al. Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV. Bull World Health Organ. 2007;85:466–73.PubMedCrossRef
8.
Zurück zum Zitat Moodley D, Moodly J, Coodavia H, et al. The South African Intrapartum Nevirapine Trial (SAINT) Investigators, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003;187:725–35.PubMedCrossRef Moodley D, Moodly J, Coodavia H, et al. The South African Intrapartum Nevirapine Trial (SAINT) Investigators, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003;187:725–35.PubMedCrossRef
Metadaten
Titel
Prevention of Parent to Child Transmission of HIV (PPTCT): An Effort of 4 Years in a Tertiary Centre
verfasst von
Sebanti Goswami
Partha Sarathi Chakravorty
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 4/2011
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-011-0056-1

Weitere Artikel der Ausgabe 4/2011

The Journal of Obstetrics and Gynecology of India 4/2011 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.